<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83229">
  <stage>Registered</stage>
  <submitdate>2/10/2008</submitdate>
  <approvaldate>8/12/2008</approvaldate>
  <actrnumber>ACTRN12608000617369</actrnumber>
  <trial_identification>
    <studytitle>Complementary and Alternative Medicine and the menopausal transition: The effect of a Chinese Herbal Formula on Vasomotor symptoms and bone turnover.</studytitle>
    <scientifictitle>A randomised placebo controlled double blind clinical trial on the effectiveness of a herbal formula to alleviate menopausal vasomotor symptoms.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Menopause</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Herbal medicine formulation in tablet form, with a dosage of 2 tablets twice per day for 16 weeks. The ingredients of the formulation remain commercial-in-confidence.</interventions>
    <comparator>Placebo oral tablets designed to look, smell and taste similar to the herbal treatment. Dosage of 2 tablets twice per day for 16 weeks.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction in the number and severity of vasomotor symptoms as recorded on the Daily Flush Diary.</outcome>
      <timepoint>Daily for 20 weeks.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in menopause related quality of life as measured by the Greene Climac Scale.</outcome>
      <timepoint>Baseline, weeks 4, 8, 12, 16, 20, 32.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in the Hot Flush Related Daily Interference Scale (HFRDI).</outcome>
      <timepoint>Baseline, weeks 4, 8, 12, 16, 20, 32.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Women with at least 12 months amenorrhoea aged between 45-65 years.
2. On average 6 episodes of vasomotor symptoms per day.</inclusivecriteria>
    <inclusiveminage>45</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Undiagnosed vaginal bleeding
2. History of breast cancer or cancer
3. Use of corticosteroids or anticoagulants
4. Uncontrolled and/or diagnosed medication conditions likely to interfere with the study treatment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants will be screened to ensure they meet the inclusion and exclusion criteria and they must also be in satisfactory health. This will be determined by physical examination and medical history, normal full blood count, liver and kidney function results. Eligible participants will then be enrolled and randomly allocated to either the active or placebo group. Medication randomisation is conducted by a computer at a central administration site where the trial medications are also labelled in numbered (coded) containers to maintain concealment for researchers.</concealment>
    <sequence>Participants will be randomised to treatment using a randomly permuted block design generated by computer and performed by a third party.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>1/08/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>90</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Global Therapeutics Pty Ltd</primarysponsorname>
    <primarysponsoraddress>PO Box 1999
Byron Bay
NSW 2481</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Global Therapeutics Pty Ltd</fundingname>
      <fundingaddress>PO Box 1999
Byron Bay
NSW 2481</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Western Sydney</sponsorname>
      <sponsoraddress>Locked Bag 1797
Penrith South DC
NSW 1797</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Royal North Shore Hospital</othercollaboratorname>
      <othercollaboratoraddress>Pacific Highway
St Leonards NSW 2065</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>The Chinese Medicine Clinical Research Centre (CMCRC), Liverpool Hospital</othercollaboratorname>
      <othercollaboratoraddress>Cnr Elizabeth &amp; Goulburn St
Liverpool NSW 2170</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Some evidence suggests that Chinese &amp; western herbs may help reduce menopausal symptoms. Therefore, this study will investigate the effectiveness of a herbal formula to alleviate menopausal vasomotor symptoms and improve quality of life. The trial will consist of two arms, an intervention and a placebo group, with random assignment of participants. All participants and trial researchers will be blinded to treatment allocation. Preliminary data will also be gathered on the effect of herbal therapy on bone metabolic markers.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Western Sydney Human Research Ethics Committee</ethicname>
      <ethicaddress>Locked Bag 1797
Penrith South DC
NSW 1797</ethicaddress>
      <ethicapprovaldate />
      <hrec>UWS HREC 04/035</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>South Western Sydney Area Health Service</ethicname>
      <ethicaddress>Locked Bag 7017
Liverpool NSW 1871</ethicaddress>
      <ethicapprovaldate />
      <hrec>04/055</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Centre for Complementary Medicine Research (CompleMED)</name>
      <address>University of Western Sydney
Locked Bag 1797
Penrith South DC
NSW 1797</address>
      <phone>02 4620 3284</phone>
      <fax />
      <email>complemed@uws.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Centre for Complementary Medicine Research (CompleMED)</name>
      <address>University of Western Sydney
Locked Bag 1797
Penrith South DC
NSW 1797</address>
      <phone>02 4620 3284</phone>
      <fax />
      <email>complemed@uws.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>